Search research articles
Contact Us
Filters
Showing results (81-90 of 199) with videos related to
Page
of 20
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2024
Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation
Christian D Rolfo, Russell W Madison, Lincoln W Pasquina, et al.
JCO Precision Oncology
|
July 12, 2021
High Sensitivity of Plasma Cell-Free DNA Genotyping in Cases With Evidence of Adequate Tumor Content
Catherine B Meador, Marina S D Milan, Emmy Y Hu, et al.
JCO Precision Oncology
|
August 17, 2022
Tumor Mutational Burden as a Predictor of First-Line Immune Checkpoint Inhibitor Versus Carboplatin Benefit in Cisplatin-Unfit Patients With Urothelial Carcinoma
Ryon P Graf, Virginia Fisher, Richard S P Huang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 9, 2022
Quantifying the Value of Multigene Testing in Resected Early Stage Lung Adenocarcinoma
Bharathi Muthusamy, Kira Raskina, Katherine T Lofgren, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Genomic Evolution in a Patient With Lung Adenocarcinoma With a Germline <i>EGFR</i> T790M Mutation
Netta Mäkinen, Meng Zhou, Meredith Bemus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 30, 2016
Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non-Small-Cell Lung Cancer
Geoffrey R Oxnard, Kenneth S Thress, Ryan S Alden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2010
A pilot study of volume measurement as a method of tumor response evaluation to aid biomarker development
Binsheng Zhao, Geoffrey R Oxnard, Chaya S Moskowitz, et al.
The Prostate
|
March 14, 2022
Clinical and pathological features associated with circulating tumor DNA content in real-world patients with metastatic prostate cancer
Emmanuel S Antonarakis, Marni Tierno, Virginia Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2011
Variability of lung tumor measurements on repeat computed tomography scans taken within 15 minutes
Geoffrey R Oxnard, Binsheng Zhao, Camelia S Sima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 10, 2012
Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations
Natasha Rekhtman, Paul K Paik, Maria E Arcila, et al.
Page
of 20
Search research articles
Search
Showing results (81-90 of 199) with videos related to
Sort By:
Page
of 20
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2024
Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation
Christian D Rolfo, Russell W Madison, Lincoln W Pasquina, et al.
JCO Precision Oncology
|
July 12, 2021
High Sensitivity of Plasma Cell-Free DNA Genotyping in Cases With Evidence of Adequate Tumor Content
Catherine B Meador, Marina S D Milan, Emmy Y Hu, et al.
JCO Precision Oncology
|
August 17, 2022
Tumor Mutational Burden as a Predictor of First-Line Immune Checkpoint Inhibitor Versus Carboplatin Benefit in Cisplatin-Unfit Patients With Urothelial Carcinoma
Ryon P Graf, Virginia Fisher, Richard S P Huang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 9, 2022
Quantifying the Value of Multigene Testing in Resected Early Stage Lung Adenocarcinoma
Bharathi Muthusamy, Kira Raskina, Katherine T Lofgren, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Genomic Evolution in a Patient With Lung Adenocarcinoma With a Germline <i>EGFR</i> T790M Mutation
Netta Mäkinen, Meng Zhou, Meredith Bemus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 30, 2016
Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non-Small-Cell Lung Cancer
Geoffrey R Oxnard, Kenneth S Thress, Ryan S Alden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2010
A pilot study of volume measurement as a method of tumor response evaluation to aid biomarker development
Binsheng Zhao, Geoffrey R Oxnard, Chaya S Moskowitz, et al.
The Prostate
|
March 14, 2022
Clinical and pathological features associated with circulating tumor DNA content in real-world patients with metastatic prostate cancer
Emmanuel S Antonarakis, Marni Tierno, Virginia Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2011
Variability of lung tumor measurements on repeat computed tomography scans taken within 15 minutes
Geoffrey R Oxnard, Binsheng Zhao, Camelia S Sima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 10, 2012
Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations
Natasha Rekhtman, Paul K Paik, Maria E Arcila, et al.
Page
of 20